A
Andreas Hahn
Researcher at University of Giessen
Publications - 9
Citations - 565
Andreas Hahn is an academic researcher from University of Giessen. The author has contributed to research in topics: Fontan procedure & Hypoplastic left heart syndrome. The author has an hindex of 7, co-authored 9 publications receiving 471 citations.
Papers
More filters
Journal ArticleDOI
Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes
Johannes R. Lemke,Dennis Lal,Eva M. Reinthaler,Isabelle Steiner,Michael Nothnagel,Michael Alber,Kirsten Geider,Bodo Laube,Michael Schwake,Katrin Finsterwalder,Andre Franke,Markus Schilhabel,Johanna A. Jähn,Hiltrud Muhle,Rainer Boor,Wim Van Paesschen,Roberto Caraballo,Natalio Fejerman,Sarah Weckhuysen,Peter De Jonghe,Jan Larsen,Rikke S. Møller,Helle Hjalgrim,Laura Addis,Shan Tang,Elaine Hughes,Deb K. Pal,Kadi Veri,Ulvi Vaher,Tiina Talvik,Petia Dimova,Rosa Guerrero López,José M. Serratosa,Tarja Linnankivi,Anna-Elina Lehesjoki,Susanne Ruf,Markus Wolff,Sarah E. Buerki,Gabriele Wohlrab,Judith Kroell,Alexandre N. Datta,Barbara Fiedler,Gerhard Kurlemann,Gerhard Kluger,Andreas Hahn,D Edda Haberlandt,Christina Kutzer,Jürgen Sperner,Felicitas Becker,Yvonne G. Weber,Martha Feucht,Hannelore Steinböck,Birgit Neophythou,Gabriel M. Ronen,Ursula Gruber-Sedlmayr,Julia Geldner,Robert J. Harvey,Per Hoffmann,Per Hoffmann,Stefan Herms,Stefan Herms,Janine Altmüller,Mohammad R. Toliat,Holger Thiele,Peter Nürnberg,Christian Wilhelm,Ulrich Stephani,Ingo Helbig,Holger Lerche,Fritz Zimprich,Bernd A. Neubauer,Saskia Biskup,Saskia Biskup,Sarah von Spiczak +73 more
TL;DR: Results establish alterations of the gene encoding the NMDA receptor NR2A subunit as a major genetic risk factor for IFE.
Journal ArticleDOI
47 patients with FLNA associated periventricular nodular heterotopia
Max Lange,Burkhard S. Kasper,Axel Bohring,Frank Rutsch,Gerhard Kluger,Sabine Hoffjan,Stephanie Spranger,Anne Behnecke,Andreas Ferbert,Andreas Hahn,Barbara Oehl-Jaschkowitz,Luitgard Graul-Neumann,Katharina Diepold,Isolde Schreyer,Matthias K. Bernhard,Franziska Mueller,Ulrike Siebers-Renelt,Ana Beleza-Meireles,G. Uyanik,Sandra Janssens,Eugen Boltshauser,Juergen Winkler,Gerhard Schuierer,Ute Hehr +23 more
TL;DR: A concerning median diagnostic latency of 17 to 20 years was noted between seizure onset and the genetic diagnosis, intensely delaying appropriate medical surveillance for potentially life threatening cardiovascular complications as well as genetic risk assessment and counseling prior to family planning for this X-linked dominant inherited disorder with high perinatal lethality in hemizygous males.
Book ChapterDOI
Outcome of Patients with Classical Infantile Pompe Disease Receiving Enzyme Replacement Therapy in Germany
Andreas Hahn,Susanne Praetorius,Nesrin Karabul,Johanna Dießel,Dorle Schmidt,Reinald Motz,Claudia Haase,Martina Baethmann,Julia B. Hennermann,Julia B. Hennermann,Martin Smitka,René Santer,Nicole Muschol,Ann Meyer,Thorsten Marquardt,Martina Huemer,Charlotte Thiels,Marianne Rohrbach,Gökce Seyfullah,Eugen Mengel +19 more
TL;DR: The data suggest that classical infantile Pompe disease still remains a life-threatening condition associated with high morbidity and often dismal prognosis, and a relevant number of patients do not benefit definitely from ERT.
Journal ArticleDOI
Structural cerebral abnormalities and neurodevelopmental status in single ventricle congenital heart disease before Fontan procedure.
Walter Knirsch,Kristina Nadine Mayer,Ianina Scheer,Ruth O'Gorman Tuura,Dietmar Schranz,Andreas Hahn,Kristina Wetterling,Ingrid A. Beck,Beatrice Latal,Bettina Reich +9 more
TL;DR: Cerebral MRI abnormalities occur in more than one third of children with single ventricle, while the neuro-developmental status is less severely affected before Fontan procedure, warranting further studies to determine aetiology and further evolution until school-age.
Journal ArticleDOI
Genetic basis of hypertrophic cardiomyopathy in children
Stefan Rupp,Moataz Felimban,Anne Schänzer,Dietmar Schranz,Christoph Marschall,Martin Zenker,Thushiha Logeswaran,Christoph Neuhäuser,Josef Thul,Christian Jux,Andreas Hahn +10 more
TL;DR: A definite genetic diagnosis can be reached in nearly 80% with HCM of childhood onset by applying next-generation sequencing and directing further diagnostics by discussing unsolved cases in a multidisciplinary board.